InnoCan Pharma Corporation INNO
CNSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -11.80% | 4.12% | 33.53% | 43.76% | 39.81% |
| Total Receivables | 37.53% | 19.91% | 76.12% | 14.56% | 83.42% |
| Inventory | -15.71% | -26.27% | -34.31% | -28.58% | -2.14% |
| Prepaid Expenses | 153.19% | 8.57% | 7.46% | -71.12% | -77.18% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 88.04% | 147.03% | 152.97% | 288.33% | 115.00% |
| Total Current Assets | -5.98% | 0.51% | 14.09% | 16.32% | 27.26% |
|
|
|||||
| Total Current Assets | -5.98% | 0.51% | 14.09% | 16.32% | 27.26% |
| Net Property, Plant & Equipment | -18.00% | -25.23% | -23.89% | -21.19% | -18.03% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | -6.09% | 0.26% | 13.63% | 15.86% | 26.63% |
|
|
|||||
| Total Accounts Payable | 54.94% | 83.71% | 27.03% | -67.42% | -40.10% |
| Total Accrued Expenses | 46.74% | 11.36% | 53.56% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -97.69% | -78.08% | -75.34% | -7.97% | -7.14% |
| Total Other Current Liabilities | -97.69% | -78.08% | -75.34% | -7.97% | -7.14% |
| Total Current Liabilities | -33.75% | -25.69% | -39.45% | 11.65% | 10.60% |
|
|
|||||
| Total Current Liabilities | -33.75% | -25.69% | -39.45% | 11.65% | 10.60% |
| Long-Term Debt | -28.55% | -25.81% | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | -32.08% | -25.73% | 2.10% | 68.99% | 62.54% |
|
|
|||||
| Common Stock & APIC | 3.86% | 5.07% | 3.88% | 4.84% | 2.43% |
| Retained Earnings | -2.66% | -4.27% | -3.22% | -9.29% | -4.57% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 14.19% | 11.18% | 8.36% | -25.19% | -12.85% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 14.19% | 11.18% | 8.36% | -25.19% | -12.85% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | 5.07% | 23.37% | 42.21% | 55.28% | 104.36% |
| Total Equity | 10.81% | 15.08% | 17.30% | -4.45% | 10.73% |
|
|
|||||